Pharmaceutical company iX Biopharma announced that it has been granted a patent in South Africa for its WaferiX drug delivery technology. The patent will expire on Oct 26, 2030. WaferiX is a fast-dissolving wafer formulation that allows drugs to be administered by placing under the tongue. Shares of iX Biopharma closed 1 cent lower at 30 cents.

To continue reading,
Sign in to access this Premium article.
Subscription entitlements:

Less than $9 per month

3 Simultaneous logins across all devices

Unlimited access to latest and premium articles

Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)
Related Stories
- Boustead Singapore closes exit offer for Boustead Projects shares
- Boustead Singapore extends offer closing date to Jan 10, 2024
- Boustead Singapore receives exit offer acceptances totalling 7,230,809 shares in Boustead Projects